AbCellera Biologics (ABCL) Payables (2020 - 2026)
AbCellera Biologics (ABCL) posted Payables of $32.48 million for Q2 2026, down 35.1% from $50.07 million a year earlier and down 17.9% from the prior quarter.
Powered by 
Analysis
AbCellera Biologics (ABCL) Payables (2020 - 2026) Analysis & Trends
At the end of FY2025, AbCellera Biologics' Payables came in at $50.78 million, down 7.7% from FY2024.
- Annual Payables shows a five-year compound annual growth rate of 20.3% (FY2020 to FY2025).
- In prior years, AbCellera Biologics' Payables was $55 million in FY2024 (+10.9%), $49.58 million in FY2023 (-5.6%), $52.5 million in FY2022 (+64.0%) and $32.02 million in FY2021 (+58.5%).
- The Q2 2026 figure stands as the lowest quarterly Payables since Q1 2023.
- On a year-over-year basis, Payables has declined in each of the last four quarters, with growth averaging 3.2% over the last eight quarters.
- The strongest year-over-year quarter for Payables in the past five years was Q2 2023, with growth of 114.8%; the weakest was Q2 2026, with a decline of 35.1%.
- According to Business Quant data, Payables for the three prior quarters was $39.55 million (Q1 2026), $50.78 million (Q4 2025) and $53.12 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 4.07 Bn |
| 10 | AbCellera Biologics | 3.83 Bn | 3.29 Bn | - | 32.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.48 Mn |
| Mar 31, 2026 | 39.55 Mn |
| Dec 31, 2025 | 50.78 Mn |
| Sep 30, 2025 | 53.12 Mn |
| Jun 30, 2025 | 50.07 Mn |
| Mar 31, 2025 | 47.84 Mn |
| Dec 31, 2024 | 55.00 Mn |
| Sep 30, 2024 | 53.77 Mn |
| Jun 30, 2024 | 43.95 Mn |
| Mar 31, 2024 | 42.89 Mn |
| Dec 31, 2023 | 49.58 Mn |
| Sep 30, 2023 | 35.71 Mn |
| Jun 30, 2023 | 52.40 Mn |
| Mar 31, 2023 | 31.81 Mn |
| Dec 31, 2022 | 52.50 Mn |
| Sep 30, 2022 | 25.87 Mn |
| Jun 30, 2022 | 24.39 Mn |
| Mar 31, 2022 | 25.72 Mn |
| Dec 31, 2021 | 32.02 Mn |
| Sep 30, 2021 | 24.07 Mn |
API Access
AbCellera Biologics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ABCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();